Feasibility and potential clinical benefit of dose de-escalation in stereotactic ablative radiotherapy for lung cancer lesions with ground glass opacities
Introduction: Treatment of neoplasic lung nodules with ground glass opacities (GGO) faces two primary challenges. First, the standard practice of treating GGOs as solid nodules, which effectively controls the tumor locally, but might increase associated toxicities. The second is the potential for do...
Saved in:
| Main Authors: | Carla Cases, Meritxell Mollà, Marcelo Sánchez, Mariana Benegas, Marc Ballestero, Sergi Serrano-Rueda, Gabriela Antelo, Carles Gomà |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-10-01
|
| Series: | Physics and Imaging in Radiation Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405631624001519 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
by: Steven Eric Finkelstein, et al.
Published: (2011-01-01) -
Stereotactic ablative radiotherapy for primary kidney cancer – An international patterns of practice survey
by: Katherine Taplin, et al.
Published: (2025-01-01) -
Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience
by: Justin Lee, et al.
Published: (2021-12-01) -
Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC
by: Chao Liu, et al.
Published: (2025-02-01) -
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
by: Xiaomin Li, et al.
Published: (2024-12-01)